Overview

The staff within the Gene Transfer, Targeting and Therapeutics Core (GT³) provide expert consultation for the safe and effective use of viral vector technologies, and offer custom design and production services for multiple viral vector types. The GT³ facilitates the use of these powerful research tools by Salk researchers and others across diverse fields of study such as systems neuroscience, stem cell biology, metabolism, ageing, cancer biology and gene therapy.

Support for the GT³: